::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

BARIATRIC SURGERY VERSUS INTENSIVE MEDICAL THERAPY IN OBESE PATIENTS WITH DIABETES.

AUTHORS:

Dr Hiba Mazhar,Dr Asfand Yar Waheed Randhawa,Dr Sana Saleem Khan Niazi.

ABSTRACT:

The aim of the current medical treatment is to cease disease progression by minimizing high glucose level, high blood pressure and other complications. Somehow there is moderate to severe glycemic control over type 2 diabetes in almost 50% of patients from pharmacotherapy management. Some studies have suggested that in severely obese patients who are suffering from type 2 diabetes could have rapidly improvement in their glycemic control and cardiovascular risk factors bariatric surgery or metabolic surgery. Some randomized studies have done the comparison between bariatric surgery and intensive medical therapy among those who are suffering from type 2 diabetes. But still there are many aspects under debate regarding the efficacy of bariatric surgery in patients having uncontrolled diabetes. The aim of the study is to compare intensive medical therapy with surgical treatment as a means of improving glycemic control in obese patients with type 2 diabetes. Theoretically, such improvements have the potential to reduce cardiovascular morbidity and mortality, as shown in nonrandomized studies, although such benefits will need to be balanced with surg obese patients with poorly controlled diabetes who underwent risk and safety as shown in larger, multicenter clinical-outcome trials.